Jian-Feng Tu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jian-Feng Tu has a total of 240 co-authors. Here are the top co-authors by number of shared publications:
- Cun-Zhi Liu
International Acupuncture and Moxibustion Innovation Institute, School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine
27 shared publications - Li-Qiong Wang
International Acupuncture and Moxibustion Innovation Institute, School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China
17 shared publications Cun-Zhi Liu
International Acupuncture and Moxibustion Innovation Institute, School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China
15 shared publications- Jing-Wen Yang
International Acupuncture and Moxibustion Innovation Institute, School of Acupuncture‐Moxibustion and Tuina Beijing University of Chinese Medicine Beijing China
14 shared publications Guang-Xia Shi
12 shared publications- Guang-Xia Shi
International Acupuncture and Moxibustion Innovation Institute, School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China
9 shared publications
Latest Publications
- 5 February 2026
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 20 (1) , 2
Brain functional basis of the association between positive expectation and acupuncture efficacy in knee osteoarthritis
Expectation is an important psychological factor affecting clinical treatment outcomes in chronic diseases; however, its underlying neural basis remains unclear. The aim of this study is to explore the neurofunctional mechanisms of expectation and investigate how expectations influence acupuncture treatment efficacy in the brains of patients with knee osteoarthritis (KOA). A total of 90 patients diagnosed with KOA were enrolled in this study. The acupuncture group (AG, age 45–65) and sham acupuncture group (SG, age 48–65) received either 12 sessions of 30-min acupuncture treatment or sham acupuncture treatment, whereas the waiting-list group (WG, age 45–65) did not receive any interventions. Patients’ baseline positive expectations were assessed. Neuroimaging, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and other clinical data were collected at baseline and after treatment (week 4). Correlation analyses between the brain imaging and clinical data were performed. Baseline expectations and improvements in WOMAC function were associated with fractional amplitude of low-frequency fluctuation (fALFF) changes in the posterior cingulate cortex (PCC)/precuneus and increased PCC/precuneus–medial prefrontal cortex (mPFC) connectivity in the AG, but not in the SG or WG. Both altered fALFF in the PCC/precuneus and enhanced PCC/precuneus–mPFC connectivity were neural correlates of the association between positive expectations and the therapeutic efficacy of acupuncture.
- 5 February 2026
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 20 (1) , 2
Brain functional basis of the association between positive expectation and acupuncture efficacy in knee osteoarthritis
Expectation is an important psychological factor affecting clinical treatment outcomes in chronic diseases; however, its underlying neural basis remains unclear. The aim of this study is to explore the neurofunctional mechanisms of expectation and investigate how expectations influence acupuncture treatment efficacy in the brains of patients with knee osteoarthritis (KOA). A total of 90 patients diagnosed with KOA were enrolled in this study. The acupuncture group (AG, age 45–65) and sham acupuncture group (SG, age 48–65) received either 12 sessions of 30-min acupuncture treatment or sham acupuncture treatment, whereas the waiting-list group (WG, age 45–65) did not receive any interventions. Patients’ baseline positive expectations were assessed. Neuroimaging, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and other clinical data were collected at baseline and after treatment (week 4). Correlation analyses between the brain imaging and clinical data were performed. Baseline expectations and improvements in WOMAC function were associated with fractional amplitude of low-frequency fluctuation (fALFF) changes in the posterior cingulate cortex (PCC)/precuneus and increased PCC/precuneus–medial prefrontal cortex (mPFC) connectivity in the AG, but not in the SG or WG. Both altered fALFF in the PCC/precuneus and enhanced PCC/precuneus–mPFC connectivity were neural correlates of the association between positive expectations and the therapeutic efficacy of acupuncture.
- Open Access
- 1 January 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-18
Electroacupuncture Alleviates KOA-Induced Pain and Cartilage Degeneration via NGF/TrkA Pathway
Knee osteoarthritis (KOA) is a chronic degenerative joint disease marked by pain, cartilage degradation, and limited mobility. Existing treatments remain suboptimal due to limited efficacy and adverse effects, highlighting the urgent need for safer, mechanism-based therapies. Electroacupuncture (EA) has demonstrated clinical benefits in KOA, yet its underlying molecular mechanisms remain unclear. A KOA rat model was established via intra-articular injection of monosodium iodoacetate (MIA). EA was applied at Dubi (ST35) and Neixiyan (EX-LE5) acupoints. We assessed the effect of EA on nociceptive behavior in rats with KOA using von Frey filament testing, weight-bearing asymmetry measurements, and spontaneous pain assays. Cartilage degeneration was analyzed via toluidine blue staining, while immunofluorescence staining quantified protein expression levels in cartilage and dorsal root ganglia (DRG). Inhibitor and agonist injections were employed to evaluate the specific involvement of the NGF/TrkA pathway in EA-mediated effects. EA significantly reduced mechanical allodynia (p < 0.001), weight-bearing asymmetry (p < 0.001), spontaneous pain (p < 0.001). EA decreased macroscopic chondropathy score (p < 0.01) and cartilage degeneration score (p < 0.001). EA inhibited MMP13 expression (p < 0.05), suppressed NGF (p < 0.001) and TrkA (p < 0.05) expression, decreased PGP9.5 overexpression (p < 0.05), and downregulated pro-inflammatory cytokines IL-1β (p < 0.01) and TNF-α (p < 0.01). Pharmacological inhibition of NGF/TrkA mimicked EA’s effects, while activation of this pathway counteracted its analgesia. EA selectively downregulated TrkA in CGRP+ (p < 0.01), but not IB4+ (p > 0.05) or NF200+ (p > 0.05) DRG neurons subtypes. Our results demonstrate that EA alleviates KOA, possibly via inhibiting NGF/TrkA pathway activation in knee joints and reducing TrkA expression in CGRP+ sensory neurons, supporting the therapeutic potential of EA for KOA.
- 1 January 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-18
Open AccessElectroacupuncture Alleviates KOA-Induced Pain and Cartilage Degeneration via NGF/TrkA Pathway
Knee osteoarthritis (KOA) is a chronic degenerative joint disease marked by pain, cartilage degradation, and limited mobility. Existing treatments remain suboptimal due to limited efficacy and adverse effects, highlighting the urgent need for safer, mechanism-based therapies. Electroacupuncture (EA) has demonstrated clinical benefits in KOA, yet its underlying molecular mechanisms remain unclear. A KOA rat model was established via intra-articular injection of monosodium iodoacetate (MIA). EA was applied at Dubi (ST35) and Neixiyan (EX-LE5) acupoints. We assessed the effect of EA on nociceptive behavior in rats with KOA using von Frey filament testing, weight-bearing asymmetry measurements, and spontaneous pain assays. Cartilage degeneration was analyzed via toluidine blue staining, while immunofluorescence staining quantified protein expression levels in cartilage and dorsal root ganglia (DRG). Inhibitor and agonist injections were employed to evaluate the specific involvement of the NGF/TrkA pathway in EA-mediated effects. EA significantly reduced mechanical allodynia (p < 0.001), weight-bearing asymmetry (p < 0.001), spontaneous pain (p < 0.001). EA decreased macroscopic chondropathy score (p < 0.01) and cartilage degeneration score (p < 0.001). EA inhibited MMP13 expression (p < 0.05), suppressed NGF (p < 0.001) and TrkA (p < 0.05) expression, decreased PGP9.5 overexpression (p < 0.05), and downregulated pro-inflammatory cytokines IL-1β (p < 0.01) and TNF-α (p < 0.01). Pharmacological inhibition of NGF/TrkA mimicked EA’s effects, while activation of this pathway counteracted its analgesia. EA selectively downregulated TrkA in CGRP+ (p < 0.01), but not IB4+ (p > 0.05) or NF200+ (p > 0.05) DRG neurons subtypes. Our results demonstrate that EA alleviates KOA, possibly via inhibiting NGF/TrkA pathway activation in knee joints and reducing TrkA expression in CGRP+ sensory neurons, supporting the therapeutic potential of EA for KOA.
- Open Access
Investigating the efficacy of electroacupuncture for postoperative ileus in patients with colorectal cancer: study protocol for a multicentre clinical trial with neuroimaging assessment
Introduction: Postoperative ileus (POI) is a prevalent complication following abdominal surgeries, significantly compromising patients’ quality of life and imposing a socioeconomic burden. Electroacupuncture (EA), a widely used therapeutic approach in China, has shown promise as an effective intervention for POI. However, the neural mechanism underlying its therapeutic effects remains unclear. Thus, this study aims to evaluate the efficacy of EA treatment for POI and investigate its central mechanism by functional MRI (fMRI). Methods and analysis: This randomised controlled clinical trial will be conducted across three hospitals in China. A total of 50 eligible patients with colorectal cancer scheduled for elective laparoscopic surgery will be randomly assigned to either the EA or sham electroacupuncture (SA) group in a 1:1 ratio. All patients will undergo 5 sessions of 30 min EA or SA over 5 consecutive days post-surgery (once daily). Resting-state fMRI (rs-fMRI) scans will be performed at baseline and the end of treatment to examine brain functional changes related to EA treatment. The primary outcome is the time to first defecation. Secondary outcomes include the time to first flatus, ambulation, tolerability of semiliquid and solid food; length of postoperative hospital stay; severity of postoperative pain, abdominal distension and nausea; frequency of postoperative nausea and vomiting episodes; rate of readmission. Postoperative complications will be monitored and documented throughout the trial duration. Credibility and expectancy evaluation, along with blinding assessment, will be conducted after the first treatment session. Pearson/Spearman correlation analysis will be performed to determine the relationship between clinical variables and rs-fMRI metrics. Ethics and dissemination: This protocol has been approved by the ethics committees of Beijing University of Chinese Medicine (number 2024BZYLL0113), Cancer Hospital Chinese Academy of Medical Sciences (number 24/323-4603), Beijing Friendship Hospital Affiliated to Capital Medical University (number 2024-P2-081-01) and Beijing Chaoyang Huanxing Cancer Hospital (number 2024-011-02). Participants will sign the paper-based informed consent form before enrolment. The results will be disseminated through peer-reviewed publications. Trial registration number: ITMCTR2024000504.
Open AccessInvestigating the efficacy of electroacupuncture for postoperative ileus in patients with colorectal cancer: study protocol for a multicentre clinical trial with neuroimaging assessment
Introduction: Postoperative ileus (POI) is a prevalent complication following abdominal surgeries, significantly compromising patients’ quality of life and imposing a socioeconomic burden. Electroacupuncture (EA), a widely used therapeutic approach in China, has shown promise as an effective intervention for POI. However, the neural mechanism underlying its therapeutic effects remains unclear. Thus, this study aims to evaluate the efficacy of EA treatment for POI and investigate its central mechanism by functional MRI (fMRI). Methods and analysis: This randomised controlled clinical trial will be conducted across three hospitals in China. A total of 50 eligible patients with colorectal cancer scheduled for elective laparoscopic surgery will be randomly assigned to either the EA or sham electroacupuncture (SA) group in a 1:1 ratio. All patients will undergo 5 sessions of 30 min EA or SA over 5 consecutive days post-surgery (once daily). Resting-state fMRI (rs-fMRI) scans will be performed at baseline and the end of treatment to examine brain functional changes related to EA treatment. The primary outcome is the time to first defecation. Secondary outcomes include the time to first flatus, ambulation, tolerability of semiliquid and solid food; length of postoperative hospital stay; severity of postoperative pain, abdominal distension and nausea; frequency of postoperative nausea and vomiting episodes; rate of readmission. Postoperative complications will be monitored and documented throughout the trial duration. Credibility and expectancy evaluation, along with blinding assessment, will be conducted after the first treatment session. Pearson/Spearman correlation analysis will be performed to determine the relationship between clinical variables and rs-fMRI metrics. Ethics and dissemination: This protocol has been approved by the ethics committees of Beijing University of Chinese Medicine (number 2024BZYLL0113), Cancer Hospital Chinese Academy of Medical Sciences (number 24/323-4603), Beijing Friendship Hospital Affiliated to Capital Medical University (number 2024-P2-081-01) and Beijing Chaoyang Huanxing Cancer Hospital (number 2024-011-02). Participants will sign the paper-based informed consent form before enrolment. The results will be disseminated through peer-reviewed publications. Trial registration number: ITMCTR2024000504.
- Open Access
- 1 December 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 6791-6805
Factors Associated with Depression, Anxiety, and Sleep Disturbance Among Patients with Moderate-to-Severe Chronic Pain: A Multicenter Cross-Sectional Study
This study aimed to investigate the prevalence of depression/anxiety/sleep disturbance (D/A/S), as well as factors associated with these conditions, among patients with moderate-to-severe chronic pain. This cross-sectional study was conducted at 13 tertiary hospitals in 10 provinces, enrolling consecutive patients with chronic pain from November 2023 to May 2024. Depression was defined using the Patient Health Questionnaire-9 cutoff of 5 or higher, categories of depression were defined as none (scores: 0–4); anxiety was defined using the Generalized Anxiety Disorder-7 cutoff of 5 or higher, categories of anxiety were defined as none (scores: 0–4); sleep disturbance was defined as a total Pittsburgh Sleep Quality Index score of > 5, categories of sleep disturbance were defined as none (scores: 0–5). Sociodemographic, lifestyle behaviors, and clinical characteristics were collected. Pearson correlation analysis was used to examine correlations among D/A/S. Univariate and multivariate logistic regression analyses were applied to identify factors associated with these conditions. A total of 1107 patients were analyzed. D/A/S were identified in 36.6%, 19.1%, and 46.3% of the patients with chronic pain, respectively. The co-occurrence of two or three symptoms was 12.8–26.6%. In the multivariate analysis, patients who reported poor self-rated health (odds ratio [OR] 1.89, 95% confidence interval [CI] 1.33–2.68) and neuroticism (OR 1.06, 95% CI 1.02–1.09) were associated with depression. Neck pain (OR 2.60, 95% CI 1.53–4.42), alcohol consumption (OR 1.83, 95% CI 1.12–2.99), neuroticism (OR 1.09, 95% CI 1.05–1.13), and pain interference (OR 1.33, 95% CI 1.17–1.50) were correlated with anxiety. Alcohol consumption (OR 1.64, 95% CI 1.16–2.32) and pain interference (OR 1.12, 95% CI 1.03–1.23) were associated with sleep disturbance. Among patients with chronic pain, D/A/S are prevalent and linked to distinct factors. Alcohol consumption and pain interference may be associated with both anxiety and sleep disturbance, while neuroticism may be linked to both depression and anxiety. Future systematic management of multifactorial factors may improve their mental health.
- 1 December 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 6791-6805
Open AccessFactors Associated with Depression, Anxiety, and Sleep Disturbance Among Patients with Moderate-to-Severe Chronic Pain: A Multicenter Cross-Sectional Study
This study aimed to investigate the prevalence of depression/anxiety/sleep disturbance (D/A/S), as well as factors associated with these conditions, among patients with moderate-to-severe chronic pain. This cross-sectional study was conducted at 13 tertiary hospitals in 10 provinces, enrolling consecutive patients with chronic pain from November 2023 to May 2024. Depression was defined using the Patient Health Questionnaire-9 cutoff of 5 or higher, categories of depression were defined as none (scores: 0–4); anxiety was defined using the Generalized Anxiety Disorder-7 cutoff of 5 or higher, categories of anxiety were defined as none (scores: 0–4); sleep disturbance was defined as a total Pittsburgh Sleep Quality Index score of > 5, categories of sleep disturbance were defined as none (scores: 0–5). Sociodemographic, lifestyle behaviors, and clinical characteristics were collected. Pearson correlation analysis was used to examine correlations among D/A/S. Univariate and multivariate logistic regression analyses were applied to identify factors associated with these conditions. A total of 1107 patients were analyzed. D/A/S were identified in 36.6%, 19.1%, and 46.3% of the patients with chronic pain, respectively. The co-occurrence of two or three symptoms was 12.8–26.6%. In the multivariate analysis, patients who reported poor self-rated health (odds ratio [OR] 1.89, 95% confidence interval [CI] 1.33–2.68) and neuroticism (OR 1.06, 95% CI 1.02–1.09) were associated with depression. Neck pain (OR 2.60, 95% CI 1.53–4.42), alcohol consumption (OR 1.83, 95% CI 1.12–2.99), neuroticism (OR 1.09, 95% CI 1.05–1.13), and pain interference (OR 1.33, 95% CI 1.17–1.50) were correlated with anxiety. Alcohol consumption (OR 1.64, 95% CI 1.16–2.32) and pain interference (OR 1.12, 95% CI 1.03–1.23) were associated with sleep disturbance. Among patients with chronic pain, D/A/S are prevalent and linked to distinct factors. Alcohol consumption and pain interference may be associated with both anxiety and sleep disturbance, while neuroticism may be linked to both depression and anxiety. Future systematic management of multifactorial factors may improve their mental health.
- Open Access
- 19 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0332268
Efficacy and neural mechanism of acupuncture for essential hypertension: Study protocol for a randomized clinical trial
Background: Hypertension is a major risk factor for cardiovascular diseases. Acupuncture has been used to control blood pressure in clinical, however, the high-quality clinical evidence is insufficient and the underlying mechanisms remain unclear. Objectives: This study aims to evaluate the efficacy of electroacupuncture for patients with essential hypertension (EH) compared with sham electroacupuncture and explore the neural mechanism. Study design and methods: his is an 8-week, parallel-grouped, randomized clinical trial. A total of 66 patients diagnosed with EH are randomly assigned (1:1) to receive either the electroacupuncture or sham electroacupuncture treatment 3 sessions per week for 4 weeks. The primary outcome is the mean systolic blood pressure change at week 4 from the baseline measurement. The independent sample t-test will be used to compare the differences between two groups. The secondary outcomes include the change in mean diastolic blood pressure, the proportion of patients with controlled blood pressure (< 140/90 mm Hg), and quality of life. The outcome variables are measured at baseline, week 2, week 4 and week 8. Functional magnetic resonance imaging scans, pulse rate variability acquisition, and image-based photoplethysmography recording are performed at baseline and the end of the intervention period to explore acupuncture-related neuroplasticity changes. Correlation analyses are performed to investigate the relationships between the neural changes and clinical symptoms. Adverse events during the trial are monitored. Trial registration: Chinese Clinical Trials Registry, the number is: ChiCTR2400082315 (https://www.chictr.org.cn/showproj.html?proj=223840).
- 19 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0332268
Open AccessEfficacy and neural mechanism of acupuncture for essential hypertension: Study protocol for a randomized clinical trial
Background: Hypertension is a major risk factor for cardiovascular diseases. Acupuncture has been used to control blood pressure in clinical, however, the high-quality clinical evidence is insufficient and the underlying mechanisms remain unclear. Objectives: This study aims to evaluate the efficacy of electroacupuncture for patients with essential hypertension (EH) compared with sham electroacupuncture and explore the neural mechanism. Study design and methods: his is an 8-week, parallel-grouped, randomized clinical trial. A total of 66 patients diagnosed with EH are randomly assigned (1:1) to receive either the electroacupuncture or sham electroacupuncture treatment 3 sessions per week for 4 weeks. The primary outcome is the mean systolic blood pressure change at week 4 from the baseline measurement. The independent sample t-test will be used to compare the differences between two groups. The secondary outcomes include the change in mean diastolic blood pressure, the proportion of patients with controlled blood pressure (< 140/90 mm Hg), and quality of life. The outcome variables are measured at baseline, week 2, week 4 and week 8. Functional magnetic resonance imaging scans, pulse rate variability acquisition, and image-based photoplethysmography recording are performed at baseline and the end of the intervention period to explore acupuncture-related neuroplasticity changes. Correlation analyses are performed to investigate the relationships between the neural changes and clinical symptoms. Adverse events during the trial are monitored. Trial registration: Chinese Clinical Trials Registry, the number is: ChiCTR2400082315 (https://www.chictr.org.cn/showproj.html?proj=223840).
- Open Access
- 30 July 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0329035
Electroacupuncture versus sham electroacupuncture in treating low anterior resection syndrome after rectal cancer surgery: Study protocol for a randomized controlled trial
Purpose: Low anterior resection syndrome (LARS), a frequent postoperative complication of rectal resection, has been shown to significantly impact patients’ quality of life. Electroacupuncture (EA), a non-pharmaceutical treatment, ameliorates gastrointestinal symptoms and promotes bowel movement. However, high-quality clinical evidence is lacking. This study aimed to determine whether EA can improve LARS symptoms compared with sham electroacupuncture (SA). Study design and methods: This multicenter, randomized, sham-controlled clinical trial will be carried out across the outpatient clinics of three tertiary medical centers in China. A total of 136 patients with LARS who meet the inclusion criteria will be randomly allocated, in equal proportions (1:1), to either the EA or SA group. Each patient will undergo treatment three times weekly during the first four weeks and twice-weekly sessions over the subsequent four weeks. After the intervention, a 24-week follow-up period will be conducted. The primary outcome is the change in the LARS score from baseline to the end of week 8. Secondary outcomes include changes in the LARS score at other time points, response rate of patients showing reduced defecation dysfunction, subjective distress related to intestinal symptoms, Wexner Diarrhea score, Bristol Bowel Diary, EORTC-QLQ-C30 Quality of Life Questionnaire, and Fecal Incontinence Quality of Life Scale. Discussion: This study will provide evidence of EA from multiple perspectives, investigate its potential application in LARS after rectal cancer surgery, and guide the development of therapy tailored to meet specific individual health needs. Ethics and dissemination: Ethical approval for this study was granted by the Ethics Committee of Beijing University of Chinese Medicine (No. 2024BZYLL0402). All participants enrolled in the trial will provide written informed consent prior to randomization. Results will be prepared for submission to a peer-reviewed academic journal. Trial registration: ITMCTR2024000195. International Traditional Medicine Clinical Trial Registry (http://itmctr.ccebtcm.org.cn/zh-CN/Home/ProjectView?pid=badb9af5-248b-4818-b3b6-25002f0fa0d5).
- 30 July 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0329035
Open AccessElectroacupuncture versus sham electroacupuncture in treating low anterior resection syndrome after rectal cancer surgery: Study protocol for a randomized controlled trial
Purpose: Low anterior resection syndrome (LARS), a frequent postoperative complication of rectal resection, has been shown to significantly impact patients’ quality of life. Electroacupuncture (EA), a non-pharmaceutical treatment, ameliorates gastrointestinal symptoms and promotes bowel movement. However, high-quality clinical evidence is lacking. This study aimed to determine whether EA can improve LARS symptoms compared with sham electroacupuncture (SA). Study design and methods: This multicenter, randomized, sham-controlled clinical trial will be carried out across the outpatient clinics of three tertiary medical centers in China. A total of 136 patients with LARS who meet the inclusion criteria will be randomly allocated, in equal proportions (1:1), to either the EA or SA group. Each patient will undergo treatment three times weekly during the first four weeks and twice-weekly sessions over the subsequent four weeks. After the intervention, a 24-week follow-up period will be conducted. The primary outcome is the change in the LARS score from baseline to the end of week 8. Secondary outcomes include changes in the LARS score at other time points, response rate of patients showing reduced defecation dysfunction, subjective distress related to intestinal symptoms, Wexner Diarrhea score, Bristol Bowel Diary, EORTC-QLQ-C30 Quality of Life Questionnaire, and Fecal Incontinence Quality of Life Scale. Discussion: This study will provide evidence of EA from multiple perspectives, investigate its potential application in LARS after rectal cancer surgery, and guide the development of therapy tailored to meet specific individual health needs. Ethics and dissemination: Ethical approval for this study was granted by the Ethics Committee of Beijing University of Chinese Medicine (No. 2024BZYLL0402). All participants enrolled in the trial will provide written informed consent prior to randomization. Results will be prepared for submission to a peer-reviewed academic journal. Trial registration: ITMCTR2024000195. International Traditional Medicine Clinical Trial Registry (http://itmctr.ccebtcm.org.cn/zh-CN/Home/ProjectView?pid=badb9af5-248b-4818-b3b6-25002f0fa0d5).
- Open Access
Acupuncture for preventing chemotherapy-induced peripheral neuropathy: study protocol for a randomised controlled trial
Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is the most prevalent non-haematological, dose-limiting adverse event associated with platinum derivatives and taxanes. Currently, no effective prophylactic interventions for CIPN have been established. However, several studies have shown that acupuncture may alleviate symptoms of peripheral neuropathy, proposing it as a potentially effective strategy for CIPN prevention. This pilot trial will help determine the feasibility and efficacy of acupuncture for preventing CIPN. The results will provide valuable insights for designing a larger clinical trial and conducting power calculations. Methods and analysis: This is a randomised sham-controlled trial. A cohort of 60 patients scheduled to receive chemotherapy will be enrolled and randomly assigned to either the electroacupuncture group or the sham acupuncture group. Eligible patients will receive nine treatment sessions administered over the course of three chemotherapy cycles. The primary outcome is the change in CIPN-related quality of life (QOL) measured by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) CIPN20 from baseline to the end of cycle three. Secondary outcomes include: neurotoxicity symptoms assessed by the Numeric Rating Scale, incidence of CIPN, chemotherapy status, insomnia symptoms measured by the Insomnia Severity Index, depression symptoms evaluated using the Beck Depression Inventory-II, anxiety symptoms assessed with the Generalised Anxiety Disorder-7 and fatigue symptoms measured by the Brief Fatigue Inventory. Adverse events will be meticulously recorded. Ethics and dissemination: The study protocol (V.1.0, 29 July 2024) has been approved by the First Affiliated Hospital of Zhengzhou University (2024-KY-0853–001). All patients will provide oral informed consent and written informed consent before participating in this study. Trial results will be disseminated in peer-reviewed publications. Trial registration number: ITMCTR2024000390 (International Traditional Medicine Clinical Trial Registry, http://itmctr.ccebtcm.org.cn/zh-CN/Home/ProjectView?pid=16387992-8971-4218-9cd0-b623af91f9f3 ), registered on 3 September 2024.
Open AccessAcupuncture for preventing chemotherapy-induced peripheral neuropathy: study protocol for a randomised controlled trial
Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is the most prevalent non-haematological, dose-limiting adverse event associated with platinum derivatives and taxanes. Currently, no effective prophylactic interventions for CIPN have been established. However, several studies have shown that acupuncture may alleviate symptoms of peripheral neuropathy, proposing it as a potentially effective strategy for CIPN prevention. This pilot trial will help determine the feasibility and efficacy of acupuncture for preventing CIPN. The results will provide valuable insights for designing a larger clinical trial and conducting power calculations. Methods and analysis: This is a randomised sham-controlled trial. A cohort of 60 patients scheduled to receive chemotherapy will be enrolled and randomly assigned to either the electroacupuncture group or the sham acupuncture group. Eligible patients will receive nine treatment sessions administered over the course of three chemotherapy cycles. The primary outcome is the change in CIPN-related quality of life (QOL) measured by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) CIPN20 from baseline to the end of cycle three. Secondary outcomes include: neurotoxicity symptoms assessed by the Numeric Rating Scale, incidence of CIPN, chemotherapy status, insomnia symptoms measured by the Insomnia Severity Index, depression symptoms evaluated using the Beck Depression Inventory-II, anxiety symptoms assessed with the Generalised Anxiety Disorder-7 and fatigue symptoms measured by the Brief Fatigue Inventory. Adverse events will be meticulously recorded. Ethics and dissemination: The study protocol (V.1.0, 29 July 2024) has been approved by the First Affiliated Hospital of Zhengzhou University (2024-KY-0853–001). All patients will provide oral informed consent and written informed consent before participating in this study. Trial results will be disseminated in peer-reviewed publications. Trial registration number: ITMCTR2024000390 (International Traditional Medicine Clinical Trial Registry, http://itmctr.ccebtcm.org.cn/zh-CN/Home/ProjectView?pid=16387992-8971-4218-9cd0-b623af91f9f3 ), registered on 3 September 2024.
- Open Access
- 9 July 2025
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 25 (1) , 1-11
Effect of acupuncture treatment for patients with knee osteoarthritis on brain fluctuation amplitude and functional connectivity: a randomized three-armed fMRI study
In clinical practice, the overall effect of a treatment includes specific and nonspecific components. Although the analgesic mechanism of specific acupuncture effect has been studied extensively, the understanding of neural basis about nonspecific placebo effect is insufficient. We aimed to reveal the neurological signatures associated with both specific effect and nonspecific effect of acupuncture in chronic pain using the functional magnetic resonance imaging (fMRI). In this three-armed, randomized controlled trial, 90 patients with knee osteoarthritis (KOA) were divided into acupuncture group (AG), sham acupuncture group (SG), or waiting list group (WG), receiving 12 times of treatments during 4 weeks. NRS, WOMAC score, and fMRI data were collected before and after treatment. We assessed the amplitude of low frequency fluctuation (ALFF) and seed-based functional connectivity (FC) to investigate the brain functional bases of the nonspecific (SG vs. WG) and specific (AG vs. SG) effects of acupuncture. Acupuncture could significantly reduce NRS score in KOA patients (overall P < 0.001). Neurally, significant ALFF changes in left dorsolateral prefrontal cortex (DLPFC) were observed in the AG (vs. SG) and SG (vs. WG; Voxel P < 0.001, Cluster P < 0.001), respectively. And the decreased ALFF values of DLPFC had a positive correlation with the NRS score changes in the SG (spearman rho = 0.592, P = 0.002). Moreover, FC between DLPFC and thalamus was increased in the AG compared to SG. And compared to WG, there was a decreased FC between DLPFC and cerebellum in the SG. The spontaneous activity of the DLPFC was involved in both the specific and nonspecific acupuncture effects, whereas different DLPFC FCs related to the specific or nonspecific effects of acupuncture. Our findings contribute to the understanding about the neuroimaging evidence of the acupuncture effects. Chinese Clinical Trial Registry ( www.chictr.org.cn ) ChiCTR1900025799. This study was registered on 9th September 2019.
- 9 July 2025
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 25 (1) , 1-11
Open AccessEffect of acupuncture treatment for patients with knee osteoarthritis on brain fluctuation amplitude and functional connectivity: a randomized three-armed fMRI study
In clinical practice, the overall effect of a treatment includes specific and nonspecific components. Although the analgesic mechanism of specific acupuncture effect has been studied extensively, the understanding of neural basis about nonspecific placebo effect is insufficient. We aimed to reveal the neurological signatures associated with both specific effect and nonspecific effect of acupuncture in chronic pain using the functional magnetic resonance imaging (fMRI). In this three-armed, randomized controlled trial, 90 patients with knee osteoarthritis (KOA) were divided into acupuncture group (AG), sham acupuncture group (SG), or waiting list group (WG), receiving 12 times of treatments during 4 weeks. NRS, WOMAC score, and fMRI data were collected before and after treatment. We assessed the amplitude of low frequency fluctuation (ALFF) and seed-based functional connectivity (FC) to investigate the brain functional bases of the nonspecific (SG vs. WG) and specific (AG vs. SG) effects of acupuncture. Acupuncture could significantly reduce NRS score in KOA patients (overall P < 0.001). Neurally, significant ALFF changes in left dorsolateral prefrontal cortex (DLPFC) were observed in the AG (vs. SG) and SG (vs. WG; Voxel P < 0.001, Cluster P < 0.001), respectively. And the decreased ALFF values of DLPFC had a positive correlation with the NRS score changes in the SG (spearman rho = 0.592, P = 0.002). Moreover, FC between DLPFC and thalamus was increased in the AG compared to SG. And compared to WG, there was a decreased FC between DLPFC and cerebellum in the SG. The spontaneous activity of the DLPFC was involved in both the specific and nonspecific acupuncture effects, whereas different DLPFC FCs related to the specific or nonspecific effects of acupuncture. Our findings contribute to the understanding about the neuroimaging evidence of the acupuncture effects. Chinese Clinical Trial Registry ( www.chictr.org.cn ) ChiCTR1900025799. This study was registered on 9th September 2019.
- Open Access
- 1 June 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 2889-2900
Acupuncture as an Adjunctive Therapy to Etoricoxib for Patients with Acute Gouty Arthritis: Protocol for a Multicenter Randomized Controlled Trial
Purpose: Acute gouty arthritis (AGA) is often managed with non-steroidal anti-inflammatory drugs. However, patients still tolerate severe pain before the analgesic takes effect. Early adjuvant analgesia is necessary in the pharmacological management of AGA. Acupuncture has the advantage of quick analgesia; nevertheless, the evidence to support the use of early-acupuncture as an adjunctive therapy for AGA is limited. This study aims to assess the efficacy of acupuncture compared with sham acupuncture on pain relief among AGA patients who are concurrently receiving etoricoxib. Patients and methods: In this multicenter, randomized, controlled trial, total 160 eligible patients with AGA will be randomly allocated into acupuncture group and sham acupuncture group in a 1:1 ratio. All patients will receive oral etoricoxib followed by 30-minute acupuncture or sham acupuncture for 1 session. The primary outcome is the change in pain intensity (Visual Analogue Scale) after the 30-minute acupuncture treatment from baseline. The secondary outcomes include tenderness of study joint, swelling of study joint, rescue medicine, credibility and expectation evaluation and blinding assessment. Adverse events will be recorded during the trial. All the patients who are randomized in this study will be included in the intention-to-treat analysis. Conclusion: The results of this study will provide evidence for acupuncture used in the treatment of acute gouty arthritis and promote clinical decisions to physicians and patients. Trial Registration: The protocol has been approved by the Medical Ethical Committee of Beijing University of Chinese Medicine (2023BZYLL0103) and registered at International Traditional Medicine Clinical Trial Registry (ITMCTR2024000218; http://itmctr.ccebtcm.org.cn/zh-CN/UserPlatform/ProjectView?pid=1749b951-b101-418f-8f82-77be3c72ea00).
- 1 June 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 2889-2900
Open AccessAcupuncture as an Adjunctive Therapy to Etoricoxib for Patients with Acute Gouty Arthritis: Protocol for a Multicenter Randomized Controlled Trial
Purpose: Acute gouty arthritis (AGA) is often managed with non-steroidal anti-inflammatory drugs. However, patients still tolerate severe pain before the analgesic takes effect. Early adjuvant analgesia is necessary in the pharmacological management of AGA. Acupuncture has the advantage of quick analgesia; nevertheless, the evidence to support the use of early-acupuncture as an adjunctive therapy for AGA is limited. This study aims to assess the efficacy of acupuncture compared with sham acupuncture on pain relief among AGA patients who are concurrently receiving etoricoxib. Patients and methods: In this multicenter, randomized, controlled trial, total 160 eligible patients with AGA will be randomly allocated into acupuncture group and sham acupuncture group in a 1:1 ratio. All patients will receive oral etoricoxib followed by 30-minute acupuncture or sham acupuncture for 1 session. The primary outcome is the change in pain intensity (Visual Analogue Scale) after the 30-minute acupuncture treatment from baseline. The secondary outcomes include tenderness of study joint, swelling of study joint, rescue medicine, credibility and expectation evaluation and blinding assessment. Adverse events will be recorded during the trial. All the patients who are randomized in this study will be included in the intention-to-treat analysis. Conclusion: The results of this study will provide evidence for acupuncture used in the treatment of acute gouty arthritis and promote clinical decisions to physicians and patients. Trial Registration: The protocol has been approved by the Medical Ethical Committee of Beijing University of Chinese Medicine (2023BZYLL0103) and registered at International Traditional Medicine Clinical Trial Registry (ITMCTR2024000218; http://itmctr.ccebtcm.org.cn/zh-CN/UserPlatform/ProjectView?pid=1749b951-b101-418f-8f82-77be3c72ea00).
- Open Access
- 26 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0316698
Electroacupuncture for acute postoperative pain during coughing after video-assisted thoracoscopic surgery: study protocol for a pilot randomized controlled trial
Background: Despite the use of multimodal analgesia regimens following video-assisted thoracoscopic surgery (VATS), acute postoperative pain persists. Electroacupuncture (EA) may alleviate acute postoperative pain following VATS; however, current evidence remains insufficient. Objectives: This trial will assess the feasibility and efficacy of EA as an adjunctive treatment compared with sham electroacupuncture (SA) for managing acute postoperative pain during coughing after VATS. Study design and methods: In this pilot randomized controlled trial, 60 patients with non-small-cell lung cancer who will undergo VATS will be randomly assigned to either the EA or SA group in a 1:1 ratio. Patients will receive standard care combined with four sessions of EA or SA within 72 h after surgery. The primary outcome will be the average postoperative pain score during coughing, measured using a numeric rating scale within 72 h after surgery. Secondary outcomes will include the average daily pain scores at rest, during coughing, and while mobilizing; incidence of chronic post-surgical pain; quality of life; cough symptom score; and analgesic consumption. All adverse events will be recorded in detail. Discussion: This study will determine whether EA as an adjunctive treatment can reduce acute postoperative pain during coughing following VATS. Trial registration: ClinicalTrial.gov ITMCTR2024000170 (http://itmctr.ccebtcm.org.cn/zh-CN/Home/ProjectView?pid=f1a344f7-7e06-4665-ad9d-0917d588eba6).
- 26 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0316698
Open AccessElectroacupuncture for acute postoperative pain during coughing after video-assisted thoracoscopic surgery: study protocol for a pilot randomized controlled trial
Background: Despite the use of multimodal analgesia regimens following video-assisted thoracoscopic surgery (VATS), acute postoperative pain persists. Electroacupuncture (EA) may alleviate acute postoperative pain following VATS; however, current evidence remains insufficient. Objectives: This trial will assess the feasibility and efficacy of EA as an adjunctive treatment compared with sham electroacupuncture (SA) for managing acute postoperative pain during coughing after VATS. Study design and methods: In this pilot randomized controlled trial, 60 patients with non-small-cell lung cancer who will undergo VATS will be randomly assigned to either the EA or SA group in a 1:1 ratio. Patients will receive standard care combined with four sessions of EA or SA within 72 h after surgery. The primary outcome will be the average postoperative pain score during coughing, measured using a numeric rating scale within 72 h after surgery. Secondary outcomes will include the average daily pain scores at rest, during coughing, and while mobilizing; incidence of chronic post-surgical pain; quality of life; cough symptom score; and analgesic consumption. All adverse events will be recorded in detail. Discussion: This study will determine whether EA as an adjunctive treatment can reduce acute postoperative pain during coughing following VATS. Trial registration: ClinicalTrial.gov ITMCTR2024000170 (http://itmctr.ccebtcm.org.cn/zh-CN/Home/ProjectView?pid=f1a344f7-7e06-4665-ad9d-0917d588eba6).